Glaukos Balance Sheet Health
Financial Health criteria checks 3/6
Glaukos has a total shareholder equity of $461.8M and total debt of $282.8M, which brings its debt-to-equity ratio to 61.2%. Its total assets and total liabilities are $940.4M and $478.6M respectively.
Key information
61.2%
Debt to equity ratio
US$282.77m
Debt
| Interest coverage ratio | n/a |
| Cash | US$295.43m |
| Equity | US$461.77m |
| Total liabilities | US$478.65m |
| Total assets | US$940.41m |
Recent financial health updates
Is Glaukos (NYSE:GKOS) A Risky Investment?
Jan 21
Health Check: How Prudently Does Glaukos (NYSE:GKOS) Use Debt?
Oct 05Is Glaukos (NYSE:GKOS) Using Debt Sensibly?
Jun 28Health Check: How Prudently Does Glaukos (NYSE:GKOS) Use Debt?
Feb 19Does Glaukos (NYSE:GKOS) Have A Healthy Balance Sheet?
Oct 16Is Glaukos (NYSE:GKOS) Using Debt Sensibly?
Jun 28Recent updates
Why Glaukos Corporation (NYSE:GKOS) Could Be Worth Watching
Apr 22Glaukos Corporation (NYSE:GKOS) Not Lagging Industry On Growth Or Pricing
Apr 04Glaukos Corporation's (NYSE:GKOS) Intrinsic Value Is Potentially 69% Above Its Share Price
Feb 21Is Glaukos (NYSE:GKOS) A Risky Investment?
Jan 21Glaukos: Remains A Hold Due To High Valuation And Negative Profitability
Jan 09Glaukos Corporation's (NYSE:GKOS) 27% Jump Shows Its Popularity With Investors
Dec 20Why Glaukos Corporation (NYSE:GKOS) Could Be Worth Watching
Nov 03Health Check: How Prudently Does Glaukos (NYSE:GKOS) Use Debt?
Oct 05Glaukos: Continued Growth Rates, Regulatory Tailwinds, And Support
Sep 01Is Glaukos (NYSE:GKOS) Using Debt Sensibly?
Jun 28Glaukos: Revising To Buy On These 3 Catalytic Factors
Jun 16Risks To Shareholder Returns Are Elevated At These Prices For Glaukos Corporation (NYSE:GKOS)
Apr 19Health Check: How Prudently Does Glaukos (NYSE:GKOS) Use Debt?
Feb 19Glaukos: Trial Momentum Building, Profitability Differentials Yet To Pull Through
Feb 14Glaukos sees positive data from mid-stage trial of dry eye treatment
Jan 10Glaukos: Show Me The Money
Nov 10Does Glaukos (NYSE:GKOS) Have A Healthy Balance Sheet?
Oct 16Glaukos pays $10M upfront to license iVeena's eye disorder therapy IVMED-80
Aug 24Glaukos: Gross Margins Compressing Despite FY22 Guidance Revision
Aug 04Glaukos gains as Stifel upgrades to Buy citing 2022 sales upside
Jul 12Is Glaukos (NYSE:GKOS) Using Debt Sensibly?
Jun 28Does Glaukos (NYSE:GKOS) Have A Healthy Balance Sheet?
Mar 14Is Glaukos (NYSE:GKOS) Using Debt Sensibly?
Nov 29Is Glaukos (NYSE:GKOS) Weighed On By Its Debt Load?
Aug 15Financial Position Analysis
Short Term Liabilities: GKOS's short term assets ($395.5M) exceed its short term liabilities ($74.0M).
Long Term Liabilities: GKOS's short term assets ($395.5M) do not cover its long term liabilities ($404.6M).
Debt to Equity History and Analysis
Debt Level: GKOS has more cash than its total debt.
Reducing Debt: GKOS's debt to equity ratio has increased from 0% to 61.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: GKOS has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if GKOS has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.